ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACTI Actividentity Corp (MM)

3.24
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Actividentity Corp (MM) NASDAQ:ACTI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.24 0 01:00:00

Active Biotech AB - Interim Report January - June 2018

09/08/2018 7:30am

GlobeNewswire


                                                                                                                                          

Second quarter in brief

  • The company's partner NeoTX presented new preclinical data for ANYARA at the AACR Annual Meeting in Chicago
  • The rights issue in April brought the company SEK 47.1 M

Events after the end of the period

  • The company announced that the Phase II LEGATO-HD trial evaluating efficacy and safety of laquinimod in Huntington's disease (HD) did not meet its primary endpoint to slow the progression of the disease. However, the secondary endpoint, reduction of brain atrophy, was met. Laquinimod showed excellent safety in the study
  • The company is initiating a scientific collaboration with the Wistar Institute in Philadelphia, PA, around tasquinimod to support future clinical development in multiple myeloma

                   
Financial summary

SEK M Apr-Jun Jan-Jun Full year
  2018 2017 2018 2017 2017
           
Net sales 5.7 5.1 10.5 9.8 20.2
Operating loss -7.3 -23.1 -15.9 -37.7 -102.5
Loss after tax -9.1 -24.4 -19.3 -40.2 -108.8
Earnings per share (SEK) -0.07 -0.20 -0.15 -0.33 -0.89
Cash and cash equivalents (at close of period)     45.6 47.7 25.2

For further information, please contact:

  Helén Tuvesson, CEO
  Tel: +46 (0)46 19 21 56

 

  Hans Kolam, CFO
  Tel: +46 (0)46 19 20 44

 
Active Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund
Tel: +46 (0)46 19 20 00

 

The report is also available at www.activebiotech.com.

Active Biotech AB - Interim Report January - June 2018



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Active Biotech via Globenewswire

1 Year Actividentity Corp (MM) Chart

1 Year Actividentity Corp (MM) Chart

1 Month Actividentity Corp (MM) Chart

1 Month Actividentity Corp (MM) Chart

Your Recent History

Delayed Upgrade Clock